Ecor1 Capital, LLC’s Atea Pharmaceuticals Inc Position
Does Ecor1 Capital, LLC own Atea Pharmaceuticals Inc (AVIR)? Not currently — the last reported position was 3.34M shares worth $11M in Q4 2024; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$11M
Q4 2024
Shares
3.34M
% of Portfolio
+0.42%
Quarters Held
13
position exited
Position History AVIR
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2024 | 3.34M | $11M | +0.42% |
| Q3 2024 | 5.44M | $18M | +0.62% |
| Q2 2024 | 5.44M | $18M | +0.55% |
| Q1 2024 | 6.15M | $25M | +0.63% |
| Q4 2023 | 7.00M | $21M | +0.55% |
| Q3 2023 | 7.00M | $21M | +0.71% |
| Q2 2023 | 7.00M | $26M | +0.64% |
| Q1 2023 | 6.18M | $21M | +0.67% |
| Q4 2022 | 6.18M | $30M | +0.91% |
| Q3 2022 | 6.18M | $35M | +1.04% |
| Q2 2022 | 6.34M | $45M | +1.55% |
| Q1 2022 | 6.34M | $46M | +1.43% |
| Q4 2021 | 5.38M | $48M | +1.53% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ecor1 Capital, LLC’s full portfolio or all institutional holders of AVIR.